Reducing sepsis in severe combined acute renal and respiratory failure by selective decontamination of the digestive tract.
Fifteen patients with severe combined acute renal and respiratory failure (SCARRF), who required mechanical ventilation and renal replacement therapy for at least 5 days, were treated with a regimen to selectively decontaminate the digestive tract (SDD). In these patients the incidence of significant infection was compared with the infection rate in 12 similar patients with SCARRF who had not received SDD, treated over the preceding 12 months. Both groups were comparable for age, study period, sepsis score, and therapeutic intervention scoring system on admission, although the Acute Physiology and Chronic Health Evaluation score was higher (p less than .05) in the SDD-treated group. Ten (83%) of 12 control patients developed definable infections compared with five (33%) of 15 in the SDD group (p less than .05). Gram-negative bacteria and fungi were responsible for 14 of the 17 infections affecting ten control patients, compared with six of the seven infections in only four SDD patients (p less than .05). The most notable site to benefit was the respiratory tract, with only one patient in the SDD group developing a pulmonary infection compared with five in the control patients (p less than .05). Urine infections may have been reduced from six (50%) of the 12 control patients to two (13%) of the 15 SDD patients, but this difference was not significant. Although survival in the control and SDD group was comparable (42% vs. 40%), mortality overall seemed related to infection. Eleven (73%) of 15 patients with definite infection died, in contrast with five (42%) of 12 who had no infections, although this was not significant.(ABSTRACT TRUNCATED AT 250 WORDS)
McClelland
P
P
Department of Anaesthesia, Royal Liverpool Hospital, UK.
Murray
A E
AE
Williams
P S
PS
van Saene
H K
HK
Gilbertson
A A
AA
Mostafa
S M
SM
Bone
J M
JM
D058186:Acute Kidney Injury / Q000150:complications*; D000328:Adult; D000368:Aged; D003428:Cross Infection / Q000382:microbiology / Q000517:prevention & control; D004064:Digestive System / Q000382:microbiology*; D005260:Female; D006801:Humans; D017053:Infection Control; D007239:Infections / Q000209:etiology / Q000382:microbiology; D007275:Injections, Intravenous; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged; D012131:Respiratory Insufficiency / Q000150:complications*